Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01154816 · OUTCOME

Serum Concentration of Alisertib on the Fourth Day of Administration Prior to the Administration of the Day 4 Dose

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia · Source last updated 2020-05-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
ng/ml
Interval / dispersion
Standard Deviation
Time frame
day 4 of protocol therapy

What was measured

Serum concentration of alisertib on the fourth day of administration prior to the administration of the day 4 dose in nanograms/milliliter.

Analysis population: Of all eligible patients enrolled, 30 provided a fourth day of administration prior to the administration of the day 4 dose sample for analysis.

Groups in this outcome

All Patients

All patients.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
All Patients30

Reported measurements

Source class 1
Values in ng/ml · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
All Patients1123.73333715.013235Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        715.013235
        value
        1123.73333
denoms
  1. counts
    1. group Id
      OG000
      value
      30
    units
    Participants
description
Serum concentration of alisertib on the fourth day of administration prior to the administration of the day 4 dose in nanograms/milliliter.
dispersion Type
Standard Deviation
groups
  1. description
    All patients.
    id
    OG000
    title
    All Patients
param Type
MEAN
population Description
Of all eligible patients enrolled, 30 provided a fourth day of administration prior to the administration of the day 4 dose sample for analysis.
reporting Status
POSTED
time Frame
day 4 of protocol therapy
title
Serum Concentration of Alisertib on the Fourth Day of Administration Prior to the Administration of the Day 4 Dose
type
SECONDARY
unit Of Measure
ng/ml

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice